http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific To Participate In 36th Annual J.P. Morgan Healthcare Conference
-
Boston Scientific to Participate in Goldman Sachs Healthcare CEOs Unscripted Conference
-
Boston Scientific (BSX) Announces FDA Approval for Vercise Deep Brain Stimulation System
-
Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System
-
Boston Scientific To Participate In BMO Capital Markets Prescriptions For Success Healthcare Conference
-
Boston Scientific Announces Update on LOTUS Edge™ Aortic Valve System
-
Boston Scientific To Participate In Citi 2017 Global Healthcare Conference
-
Boston Scientific To Participate In Piper Jaffray 29th Annual Healthcare Conference
-
New Societal Guidelines Recommend Subcutaneous Implantable Cardioverter-Defibrillator for Patients with Ventricular Arrhythmias at Risk of Sudden Cardiac Death
-
Boston Scientific To Participate In Stifel 2017 Healthcare Conference
-
Boston Scientific To Participate In 26th Annual Credit Suisse Healthcare Conference
-
Boston Scientific (BSX) Says Five-year Follow-up Data Shows WATCHMAN Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy
-
Five-year Follow-up Data Demonstrate the WATCHMAN™ Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy
-
Pre-Open Movers 10/26: (MNOV) (BWLD) (TWTR) Higher; (IDRA) (CELG) (NTRI) Lower (more...)
-
Boston Scientific Announces Results For Third Quarter 2017
-
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2017
-
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
-
Boston Scientific (BSX) to Acquire Apama Medical for $175M Up-Front Plus $125M Contigent
-
Boston Scientific Announces Agreement to Acquire Apama Medical
-
Boston Scientific To Webcast Conference Call Discussing Third Quarter 2017 Financial Results
-
Boston Scientific (BSX) Granted FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate Devices
-
Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic
-
Boston Scientific (BSX) Announces Late-Breaking Data for HeartLogic Heart Failure Diagnostic
-
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic
-
Boston Scientific To Participate In Morgan Stanley Global Healthcare Conference
-
Boston Scientific To Participate In Wells Fargo 2017 Healthcare Conference
-
Boston Scientific To Participate In 2017 Canaccord Genuity Growth Conference
-
Boston Scientific Announces Results for Second Quarter 2017
-
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2017 Financial Results
-
Boston Scientific (BSX) Sees 25% Adjusted Operating Margin in 2017 and 28% in 2020
-
Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
-
Boston Scientific (BSX) Announces CE Mark for Vercise Gevia Deep Brain Stimulation System
-
Boston Scientific Receives CE Mark for Vercise™ Gevia™ Deep Brain Stimulation System
-
Boston Scientific (BSX) Reports Positive Outcomes From Prospective Study of Bronchial Thermoplasty in PAS2
-
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
-
Boston Scientific to Participate in 2017 UBS Global Healthcare Conference
-
The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year
-
Boston Scientific Closes Symetis Acquisition
-
Boston Scientific (BSX) Announces Positive European Registry Results For WATCHMAN
-
Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device
-
New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints
-
Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients
-
Boston Scientific Announces Schedule of Presentations at EuroPCR 2017
-
Boston Scientific (BSX) Granted FDA Approval for Resonate ICD and CRT-D Systems
-
Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices
-
Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017
-
Boston Scientific to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
-
Boston Scientific Announces Results For First Quarter 2017
-
Boston Scientific Initiates Global Study To Assess Sudden Cardiac Arrest Prevention Therapy In Patients With Diabetes Who Have Previously Experienced A Heart Attack
-
Boston Scientific To Webcast Conference Call Discussing First Quarter 2017 Financial Results And Announces Revised Date For 2017 Investor Day

